Blue Cross Sues Takeda, Eli Lilly Over Actos Cancer Costs

By Andrew Scurria (June 11, 2014, 8:07 PM EDT) -- Blue Cross and Blue Shield of Massachusetts Inc. launched a flurry of subrogation actions Wednesday in the Louisiana multidistrict litigation over the bladder cancer risks carried by Takeda Pharmaceuticals Co. Ltd. and Eli Lilly & Co.'s diabetes drug Actos, seeking to recoup the cost of medical bills for hundreds of alleged victims.

Standing in the shoes of its insureds, Blue Cross and its subsidiary Blue Cross and Blue Shield of Massachusetts HMO Blue Inc. filed more than 10 cases asserting that Takeda and Eli Lilly should shoulder health coverage payouts surrounding its subrogees' personal injuries.

The defendants — Asia's largest pharmaceutical...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!